01 33EVOFEM INC
01 210335390
02 210682338
03 410849884
04 210857133
05 411000507
06 411000508
07 411020377
08 411324721
09 211602522
10 411684607
11 112280037
01 33Blank
01 32Y
02 1Blank
01 282035-09-04
02 42035-09-16
03 12041-12-11
Patent Expiration Date : 2035-09-04
US Patent Number : 10335390
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209363
Patent Use Code : U-2583
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-09-04
Patent Expiration Date : 2041-12-11
US Patent Number : 12280037
Drug Substance Claim :
Drug Product Claim :
Application Number : 209363
Patent Use Code : U-3302
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-12-11
Patent Expiration Date : 2035-09-04
US Patent Number : 11000507
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209363
Patent Use Code : U-3302
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-09-04
Patent Expiration Date : 2035-09-04
US Patent Number : 11000507
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209363
Patent Use Code : U-3270
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-09-04
Patent Expiration Date : 2035-09-04
US Patent Number : 11020377
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209363
Patent Use Code : U-3302
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-09-04
Patent Expiration Date : 2035-09-04
US Patent Number : 11020377
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209363
Patent Use Code : U-3270
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-09-04
Patent Expiration Date : 2035-09-04
US Patent Number : 11000508
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209363
Patent Use Code : U-3302
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-09-04
Patent Expiration Date : 2035-09-04
US Patent Number : 11000508
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209363
Patent Use Code : U-3270
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-09-04
Patent Expiration Date : 2035-09-04
US Patent Number : 10682338
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209363
Patent Use Code : U-3270
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-09-04
Patent Expiration Date : 2035-09-04
US Patent Number : 10849884
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209363
Patent Use Code : U-3270
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-09-04
